ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Thousand Oaks Sleep Apnea Tracking: Telemedicine Consultations Available

Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) now offers telemedicine consultations through the AASM SleepTM platform, providing patients with faster diagnosis and treatment options for sleep disorders.

-- Southern California Pulmonary and Sleep Disorders Medical Center has expanded its sleep disorder treatment options to include telemedicine consultations and advanced home sleep testing technology. The Thousand Oaks-based facility now provides remote care through the AASM SleepTM platform alongside its WatchPAT ONE home sleep apnea testing devices.

To learn more about telemedicine sleep consultations, go to https://www.sleepmd4u.com

Sleep apnea affects approximately 30 million Americans, with the majority of moderate to severe cases remaining undiagnosed, according to the American Sleep Apnea Association. Traditional sleep studies often require overnight stays at medical facilities, creating barriers for patients who struggle with unfamiliar environments or scheduling conflicts.

The center's telemedicine service eliminates travel time and waiting room delays while maintaining HIPAA-compliant security standards. Patients can schedule video consultations, complete sleep questionnaires, and track sleep patterns through integrated digital tools. The platform supports real-time interaction between patients and sleep specialists without requiring in-person visits.

Dr. Ronald Popper, the center's medical director who has provided sleep disorder care since 1984, offers diagnosis and treatment recommendations through the telemedicine platform. The WatchPAT ONE device complements these virtual consultations by enabling accurate home-based sleep apnea testing.

The FDA-cleared WatchPAT ONE uses a three-point contact design with a chest sensor, wrist bracelet, and finger probe. The device monitors seven different channels during sleep and transmits data through a smartphone app to cloud-based analysis systems. Results become available within 24 to 48 hours, unlike traditional testing methods that may take weeks.

The disposable testing device allows patients to conduct sleep studies in their own bedrooms rather than clinical sleep labs. This approach captures more representative sleep patterns while reducing costs associated with overnight facility stays.

The center accepts Medicare, all PPO plans, and entertainment industry insurance, including Motion Picture Health, Writers Guild, Directors Guild, and Screen Actors Guild plans for telemedicine consultations. Most insurance providers cover medically necessary sleep studies when proper pre-authorization is obtained through consultation or physician referral with supporting documentation.

For more information about WatchPAT home sleep testing and telemedicine services, visit https://www.sleepmd4u.com

Contact Info:
Name: Ronald A. Popper, MD, FCCP, FAASM, DABSM
Email: Send Email
Organization: Southern California Pulmonary and Sleep Disorders Medical Center
Address: 317 S. Moorpark Road, Thousand Oaks, CA 91361, United States
Website: https://sleepmd4u.com

Source: PressCable

Release ID: 89169721

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.